ArticleNuclear medicine communications2016

Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.

Ronald J Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.